Photo credit
Vicente Verez
Fellow
Verez Bencomo Vicente
General Director
Current nationality
Cuba
Current country of residence
Cuba
Past nationality
Cuba
Biodata
Verez Bencomo is a chemist dedicated to understand the molecular basis of protection from infectious disease and to use this knowledge for the development of vaccines. He led this development from bench to introduction into preventive medical practice for 5 different vaccines: The first was Quimi-Hib, a conjugate vaccine against Haemophilus influenza type b using for the first time a synthetic carbohydrate antigen (Science, 2004) and prequalified by the World Health Organization. Quimi-Vio, a conjugate vaccine including the most prevalent Streptococcus pneumoniae serotypes actually in the last clinical steps before commercial introduction in Cuba. In the period 2020-2021 during the COVID19 pandemic, he also led the development of a series of 3 vaccines call SOBERANAS. SOBERANA 02 is the only conjugate vaccine developed. The safety record of this vaccine platform allowed a quick introduction in children in Cuba as early as September 2021 allowing Cuba to be the first country in the world mass vaccinating children against COVID-19. He is “Knight of the Legion of Honor”, (France, 2015) and “National Hero” (Cuba, 2021)
Sustainable Development Goals
Keywords
pediatric vaccines, conjugate vaccines
ELECTED
2007
Place of birth
Havana
Country of birth
Cuba
DATE OF BIRTH
25
June
1953
Section
04. Chemical Sciences
cv-2022.docx
159.24 KB
Country where living and working for the majority of the last 10 years
Cuba
Public contact information
PHONE
+5372086086
ADDRESS
Finlay Vaccine Institute, Havana, Cuba
List of publications
list_of_paper_2022.docx
22.4 KB
Last updated on 12/07/2023